Adapting Breast Cancer Treatment Based on Initial Response

Sara M. Tolaney, MD, MPH

April 24, 2023

Sara M. Tolaney, MD, MPH, describes how in the past decade, there has been a shift in practice to allow for an adaptive approach based on a patient's response to preoperative therapy.

She cites the KATHERINE study as an example where data showed that use of T-DM1 in patients with residual invasive HER2-Positive breast cancer reduced recurrences by half. These data are a prime example that demonstrate how understanding a patient's response to therapy can lead to better outcomes.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Adapting Breast Cancer Treatment Based on Initial Response - Medscape - Apr 24, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Adapting Breast Cancer Treatment Based on Initial Response

Tables

Authors and Disclosures

Authors and Disclosures

Expert

Sara M. Tolaney, MD, MPH

Comments

Email This

Feedback